Cytokine Signalling Forum

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Informações:

Sinopsis

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patients with RA initiating b/tsDMARDS, and the evolution of JAKi prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers.